Medications for the secondary prevention of ischaemic heart disease and heart failure are underutilized in dialysis patients.
We determined the prescription rates of medications for the secondary prevention of ischaemic heart disease and left ventricular systolic dysfunction in stable dialysis patients. In patients with established ischaemic heart disease, statins, beta-blockers and renin-angiotensin-aldosterone system blockers were substantially underprescribed. Furthermore, beta-blockers and renin-angiotensin-aldosterone system blockers were prescribed in less than half of those with left ventricular systolic dysfunction. Contraindications to treatment were infrequent and did not explain these findings.
Ranchord
A M
AM
Department of Cardiology, Wellington Hospital, Wellington, New Zealand. anil.ranchord@ccdhb.org.nz
Harding
S A
SA
Pidgeon
G
G
D002317:Cardiovascular Agents / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000517:prevention & control; D006435:Renal Dialysis / Q000706:statistics & numerical data
D002317:Cardiovascular Agents